Cargando…
CRISPR activation screen identifies TGFβ-associated PEG10 as a crucial tumor suppressor in Ewing sarcoma
As the second most common pediatric bone and soft tissue tumor, Ewing sarcoma (ES) is an aggressive disease with a pathognomonic chromosomal translocation t(11;22) resulting in expression of EWS-FLI1, an “undruggable” fusion protein acting as transcriptional modulator. EWS-FLI1 rewires the protein e...
Autores principales: | Saratov, Vadim, Ngo, Quy A., Pedot, Gloria, Sidorov, Semjon, Wachtel, Marco, Niggli, Felix K., Schäfer, Beat W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225990/ https://www.ncbi.nlm.nih.gov/pubmed/35739280 http://dx.doi.org/10.1038/s41598-022-12659-7 |
Ejemplares similares
-
Author Correction: CRISPR activation screen identifies TGFβ-associated PEG10 as a crucial tumor suppressor in Ewing sarcoma
por: Saratov, Vadim, et al.
Publicado: (2022) -
Inhibition of HDACs reduces Ewing sarcoma tumor growth through EWS-FLI1 protein destabilization
por: Pedot, Gloria, et al.
Publicado: (2022) -
USP19 deubiquitinates EWS-FLI1 to regulate Ewing sarcoma growth
por: Gierisch, Maria E., et al.
Publicado: (2019) -
Combined Inhibition of Epigenetic Readers and Transcription Initiation Targets the EWS-ETS Transcriptional Program in Ewing Sarcoma
por: H.S. Richter, Günther, et al.
Publicado: (2020) -
YAP/TAZ inhibition reduces metastatic potential of Ewing sarcoma cells
por: Bierbaumer, Lisa, et al.
Publicado: (2021)